-- Kamada Gains to Two-Month High on Its 2012 Revenue Forecast
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-04-01T08:49:04Z
-- http://www.bloomberg.com/news/2012-04-01/kamada-gains-to-two-month-high-on-its-2012-revenue-forecast.html
Kamada Ltd. (KMDA)  rose to the highest
level in more than two months after the biopharmaceutical
company forecast 257 million shekels ($69 million) revenue for
2012.  The  shares  advanced 4.7 percent to 22.40 shekels as of
11:17 a.m. in  Tel Aviv , the highest intraday level since Jan.
19, giving the Nes Ziona, Israel-based company a market value of
618.6 million shekels.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  